Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
6.01
+0.42 (7.51%)
At close: May 12, 2025, 4:00 PM
6.00
-0.01 (-0.17%)
After-hours: May 12, 2025, 7:58 PM EDT
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,611,169
Market Cap
462.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALT News
- 4 days ago - Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™ - GlobeNewsWire
- 6 days ago - Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025 - GlobeNewsWire
- 11 days ago - Altimmune to Present at Upcoming EASL International Liver Congress™ 2025 - GlobeNewsWire
- 12 days ago - Altimmune to Participate in the Citizens Life Sciences Conference - GlobeNewsWire
- 2 months ago - Altimmune: Pemvidutide Differentiation Advancement In MASH Space Continues To Shine - Seeking Alpha
- 2 months ago - Altimmune to test obesity drug for alcohol use disorder and related health conditions - Reuters
- 2 months ago - Altimmune to Host Virtual R&D Day on March 13, 2025 - GlobeNewsWire
- 2 months ago - Altimmune to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire